Indonesia’s Bio Farma Awaiting Gov’t Nod for IndoVac Clinical Trials on Children

The World Health Organization (WHO) has not set children aged six to 11 as a high-priority group, he added.

He said that clinical trials of the IndoVac vaccine for adolescents are targeted to be completed by the end of this year.

As part of efforts to boost community immunity against Covid-19, the Indonesian government rolled out a nationwide vaccination program on Jan. 13, 2021, targeting as many as 234,666,020 citizens.

The National Covid-19 Task Force recorded that as of Dec. 12 this year, as many as 203,833,159 Indonesians have received the first vaccine dose, 174,449,231 received the second dose, 67,522,970 have taken the third dose or first booster, and 1,018,280 have received the fourth dose or second booster.

Source: State News Antara